Patent · US Active

Methods, systems, and compositions relating to miRNA-146a

US9670490B2 · kind B2 · utility

2Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2014
Grant dateJun 6, 2017
Priority date
Expiry dateJan 22, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Some embodiments comprise methods, systems, and compositions to promote, improve and/or increase neuronal differentiation, oligodendrocyte differentiation, or neurological outcome or function in a patient in need thereof. Some embodiments also comprise the administration a composition comprising a pharmaceutically effective amount of one or more of a group comprising microRNA-146a, a promoter of microRNA-146a expression, a microRNA-146a mimic, thymosin beta 4, and a phosphodiesterase 5 inhibitor to treat neurological conditions, disease, or injury in mammals, including in human beings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.